| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Graduate School of Bioagricultural Sciences (M.K., H.T., Y.U., K.Iw., S.Y., K.-I.M.), Nagoya University, Nagoya 464-8601; Faculty of Science (S.A., K.In.), Saitama University, Saitama 338-8570; and Frontier Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd. (H.M., T.O., H.M.), Ibaraki 300-4293, Japan
Address all correspondence and requests for reprints to: Kei-Ichiro Maeda, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan. E-mail: keimaeda{at}agr.nagoya-u.ac.jp.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
is found in the POA but not colocalized in GnRH neurons (2). The mediobasal hypothalamus is another candidate for the site of positive feedback action of estrogen to induce GnRH/LH surge (3). The arcuate nucleus (ARC) has been suspected to be one of the sites for the estrogen-positive feedback effect on GnRH/LH release in rats (4, 5) and ewes (6). Thus, the central site of positive feedback action of estrogen on GnRH/LH secretion still remains to be determined. Metastin was first isolated from human placenta and proposed to be the natural ligand for a G protein-coupled receptor, GPR54, also known as AXOR12 and hOT7T175 (7). It was recently reported that peripheral (8) or intracerebroventricular (icv) (9) injection of the peptide induces a profound stimulation of LH secretion in prepubertal rats, and that a genetic alteration leading to homozygous loss of function of GPR54 impairs pubertal development in mice (10). In adult males, icv (9) or peripheral (11) administration of metastin has been reported to stimulate LH secretion. In addition, metastin injection exerts no stimulation on LH release in GPR54 knockout mice, and central administration of metastin stimulates GnRH release in sheep (12). Thus, GPR54 and metastin may play a role in regulating the activity of the reproductive axis.
The present study sought to determine whether metastin plays a physiological role in inducing ovulation through stimulating the surge mode of GnRH/LH secretion to control estrous cyclicity in the female rat.
| Materials and Methods |
|---|
|
|
|---|
All the animal experiments were approved by the Committee on Animal Experiments of the Graduate School of Bioagricultural Sciences, Nagoya University.
Real-time RT-PCR
Expression of GPR54 (a) and KiSS-1 mRNA (b) was determined by quantitative RT-PCR in the POA, ARC-ME (median eminence) region and anterior pituitary obtained from cycling female rats at 0900, 1200, and 1500 h of proestrus or at 1400 h of estrus or diestrus d 1 and 2. The tissues were also collected from OVX rats with sc E2 implants to keep a low or high plasma level or without steroid treatment at 14:00 h. Real-time RT-PCR analysis (TaqMan) was performed using ABI PRISM 7900HT (PE Applied Biosystems, Foster City, CA). Briefly, DNA-free total RNA was purified from the punched-out hypothalamic tissues using RNeasy Mini kit and ribonuclease-free deoxyribonuclease Set (QIAGEN, Valencia, CA) following the manufacturers instructions. cDNA from each RNA sample was synthesized with oligo (deoxythymidine) primer at 50 C using SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA). Forward primer, reverse primer, and TaqMan probe for rKiSS-1 were 5'-ATGATCTCGCTGGCTTCTTGG-3', 5'-GGTTCACCACAGGTGCCATTTT-3', and 5'-(FAM, 6-carboxy-fluorescein)-TGCTTCTCCTCTGTGTGGCCTCTTTTGG-(TAMRA, 6-carboxytetramethyl-rhodamine)-3', respectively. Those for ß-Actin were 5'-ATGAGCTGCCTGACGGTCAG-3', 5'-GGAAGGCTGGAAGAGAGCCT-3', and 5'-(FAM)-TTCCGATGCCCTGAGGCTCTTTTCCA-(TAMRA)-3', respectively. Those for rGPR54 were described elsewhere (15). The copy number of rKiSS-1 and rGPR54 transcript was normalized to the ratio to the copy number of the ß-actin transcript for each sample.
Preparation of monoclonal antibodies
Rat metastin(152) comprising 52-amino acid residues with a disulfide bonding between Cys4 and Cys18 and an amidated C terminus (15) was chemically synthesized using a solid-phase peptide synthesizer. For immunogens, keyhole limpet hemocyanin (10 nmol) was maleimidated with N-(
-maleimidobutyryloxy) succinimide and then conjugated with [Cys36]rat metastin(3652) (CEKDMSAYNWNSFGLRY-NH2) (570 nmol). The immunogen (40 µg/mouse) together with complete or incomplete Freunds adjuvant was sc injected into BALB/c mice (female, 8 wk old) at 3-wk intervals. Four days after iv injection of immunogen (50 µg), spleen cells were fused with mouse myeloma cells P3-X63Ag8-U1 as described previously (16). The antirat rMet-3Ca monoclonal antibody (nos. 156 and 254) was then purified from ascites fluid with a protein A-immobilized column (IPA-300; Repligen, Cambridge, MA).
The antibody reactivity (No. 156) was investigated in the same manner described previously (17) using horseradish peroxidase-labeled [Cys36] rat metastin (3652) (15) in competitive enzyme immunoassy with rat metastin and human metastin. Because we found several hybridoma clones producing antibodies specific to the carboxyl-terminal RY-NH2 structure, the reactivity was tested for the following peptides as well: neuropeptide Y (NPY) with RY-amide, adrenomedullin (AM) with GY-NH2, atrial natriuretic peptide (ANP) with RY-OH, or melanin-concentrating hormone (MCH) without related structure as negative control.
To check the neutralizing activity of the antibody (No. 156), a stable Chinese hamster ovary (CHO) cell line that expressed rat GPR54 (OT7T175) was constructed by transfection of pAKKO expression vector harboring rat GPR54 to CHO dhfr cells. Antirat prolactin-releasing peptide monoclonal antibody (P2L-1T) and antihuman metastin monoclonal antibody (KIS-1N) were prepared as described previously (16, 18). Rat metastin (at 30 nM) was preincubated with purified monoclonal antibodies, rMet-3Ca, P2L-1T, or KIS-1N (at 30, 300, or 3000 nM) at room temperature for 1 h. The mixture was then subjected to the fluorometric imaging plate reader (FLIPR) assay (7) with GPR54-expressing CHO cells at the final metastin concentration of 10 nM and antibody concentration of 101000 nM. Briefly, the cells were inoculated at 30,000 cells/well in 96-well black-walled plates, cultured overnight, and allowed to incorporate a calcium sensing dye, Fluo 3-AM, for 1 h in HEPES-buffered Hanks solution (H-HBSS) including Pluronic F-127, fetal bovine serum, and Probenecid. After washing the cells with H-HBSS four times, the cells were challenged by the metastin-antibody mixture in an FLIPR device. The fluorescence intensity was monitored for 180 sec after metastin challenge.
The other antibody (No. 254), which was used for immunocytochemistry, showed a similar cross-reactivity and neutralizing activity (data not shown).
Immunocytochemistry
Ovariectomized or proestrous rats were perfused with 4% paraformaldehyde at 1400 h, and the brains were quickly removed. Frozen frontal sections (50 µm) obtained with a cryomicrotome were incubated with antirat metastin monoclonal antibody (No. 254) at 0.49 µg/ml for 24 h and then with Alexa488-conjugated goat antimouse IgG (Molecular Probes, Inc., Eugene, OR). No immunoreactivity was found with antirat metastin monoclonal antibody absorbed with 105 M synthetic C-terminal (3652) of rat metastin for 2 h at 37 C. Rabbit anti-ER (estrogen receptor)
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA), rabbit anti-c-Fos (Santa Cruz) and rabbit anti-LH-RH (Sanbio, Uden, The Netherlands) polyclonal antibodies were used. We relied on the validation by the commercial suppliers for the specificity of the anti-ER
, c-Fos, and GnRH. For dual fluorescence immunocytochemistry of metastin and either ER
or c-Fos, ER
or c-Fos was visualized with Alexa594-conjugated goat antirabbit IgG (Molecular Probes, Inc.) in red. For the double immunostaining of metastin and GnRH, metastin and GnRH were visualized with diaminobenzidine in brown and 4-Cl-1-Naphthol in blue after the avidin-biotin peroxidase complex method.
Brain injection of metastin or antirat metastin
A guide cannula (Plastics One, Roanoke, VA) was stereotaxically implanted into the third ventricle (3V) (22G) or POA (26G) at least 1 wk before the drug injection according to a rat brain atlas (19). The stereotaxic coordinates were as follows: 3V, 0.8 mm posterior and 7.5 mm ventral to bregma at midline, POA; 0.3 mm posterior and 8.4 mm ventral to bregma and 0.4 mm lateral from midline. Metastin dissolved in ultra-pure water was injected through an internal cannula (28G for 3V and 33G for the POA), which was inserted through the guide cannula. Metastin solution was injected for 2 min with a microinfusion pump into the 3V at 1 µl/min or into the POA at 0.25 µl/min. Control animals were treated with PBS or nonimmunized mouse IgG in a similar manner.
To determine the role of endogenous metastin in regulating LH surges or estrous cyclicity, monoclonal antirat metastin antibody (No. 156) was infused into the POA through the internal cannula at 1 µl/h with an osmotic mini-pump (Alzet, Cupertino, CA) for 1 wk to determine the effect on estrous cycle or with an microinfusion pump on the proestrous day from 10001800 h to determine the effect on LH surge. PBS was administered in a similar manner in the corresponding control groups.
At the end of experiments, animals were injected with brilliant blue through the internal cannula, and the cannula placement was verified by the naked eye for 3V injection or histology for the POA injection.
RIA for LH
Plasma LH concentrations were determined with RIA using a rat LH RIA kit obtained from the National Hormone and Pituitary Program and are expressed in terms of NIADDK rat LH RP-3. The least detectable LH concentration was 0.16 ng/ml for 50 µl plasma, and the intra- and interassay coefficients of variation were 5.6% at 2.3 ng/ml and 6.4% at 1.4 ng/ml, respectively.
Statistics
The effect of metastin injection into the 3V or POA and effect of antimetastin injection into the POA were analyzed by one-way ANOVA with repeated measures. Significant differences in the numbers of cells between diestrus and proestrus were determined by Students t test. Statistical differences in the levels of mRNA expression of each brain area between various treatments were determined by one-way ANOVA followed by Bonferroni test.
| Results |
|---|
|
|
|---|
|
|
|
immunoreactivities in most metastin neurons in the ARC (Fig. 4C
|
|
| Discussion |
|---|
|
|
|---|
The present study is the first to demonstrate that endogenous metastin could play a critical role in regulating GnRH/LH surge, ovulation and then estrous cycle, because the POA infusion of a specific antimetastin antibody into the POA to neutralize the locally released metastin in the POA, served to block preovulatory LH surge and disrupted estrous cyclicity. It is likely that metastin neurons located in the ARC are associated with endogenous metastin release to induce proestrous GnRH/LH release because the ARC metastin neurons express c-Fos at proestrous afternoon. The brain mechanism mediating estrogen-positive feedback action on GnRH/LH has been a central but controversial issue in reproductive physiology. Goodman (1) first reported that an E2 microimplant in the POA-induced LH surge in OVX rats and suggested that the site of estrogen-positive feedback action resides in the POA. On the other hand, there are several lines of evidence indicating that the positive feedback action site resides in the MBH in sheep (3) and monkeys (22).
Previous studies (2, 23) have revealed that GnRH neurons in the POA do not contain ER
, and the positive feedback action of estrogen on GnRH neurons has been suggested to be conveyed by ER
-containing neurons other than GnRH neurons (24). Taken together with the present results, the proestrous increase in circulating estrogen may induce metastin release in the POA to induce proestrous LH surge and regulate estrous cyclicity. Thus, metastin neurons in the ARC may be a target of estrogen feedback action during the preovulatory period to induce metastin release in the POA and then GnRH/LH surge in female rats. It still remains to be determined whether the POA is the metastin action site to induce preovulatory LH surge because the diffusion of metastin or antimetastin injected into the POA was not assessed in the present study.
Metastin production is negatively regulated by estrogen because the expression of KiSS-1 mRNA in the ARC was lowest at proestrous afternoon, highest at diestrus 2, and was increased by ovariectomy and decreased by estrogen treatment. This is consistent with a previous study showing that the KiSS-1 mRNA level is lower at proestrus or estrus than at diestrous d 1 during the rat estrous cycle (9). The change in metastin mRNA expression seems inconsistent with the change in the number of ARC metastin neurons or c-Fos expression in the metastin neurons. One explanation is that metastin is accumulated during the diestrus until the proestrus and that the metastin neurons are activated by estrogen to release metastin in proestrous afternoon to stimulate GnRH in the POA because the neurons express c-Fos in proestrous afternoon at 1400 h. The inhibitory action of estrogen on metastin production could be important because it might trigger a shut-down of LH release in the proestrous afternoon. It is also possible that estrogen facilitates metastin-metastin connections within the ARC for an excitation of the metastin neurons during proestrus. In the present study, the number of metastin neurons increased at proestrus with many fibers in the ARC. Estrogen may cause a synaptic remodeling of the ARC metastin neuronal network. Results from the group of Naftolin (5) demonstrated that estrogen causes synaptic remodeling in the ARC before the preovulatory LH surge. Further studies will be needed to clarify the relationship between metastin mRNA and estrogen feedback action on LH release.
In conclusion, the present study suggests that metastin neurons located in the ARC and projecting to the POA are one of the targets of estrogen-positive feedback action to release metastin into the POA, stimulate GnRH/LH surge during proestrus, and regulate estrous cycle in the female rat.
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: AM, Adrenomedullin; ANP, atrial natriuretic peptide; ARC, arcuate nucleus; CHO, Chinese hamster ovary; E2, estradiol; ER, estrogen receptor; FAM, 6-carboxy-fluorescein; FLIPR, fluorometric imaging plate reader; GPR, G protein-coupled receptor; icv, intracerebroventricular; MCH, melanin-concentrating hormone; ME, median eminence; NPY, neuropeptide Y; OVX, ovariectomized; POA, preoptic area; TAMRA, 6-carboxytetramethyl-rhodamine; 3V, third ventricle.
Received February 15, 2005.
Accepted for publication June 13, 2005.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Roa, E. Vigo, J. M. Castellano, F. Gaytan, D. Garcia-Galiano, V. M. Navarro, E. Aguilar, F. A. Dijcks, A. G. H. Ederveen, L. Pinilla, et al. Follicle-Stimulating Hormone Responses to Kisspeptin in the Female Rat at the Preovulatory Period: Modulation by Estrogen and Progesterone Receptors Endocrinology, November 1, 2008; 149(11): 5783 - 5790. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, K. Lee, and A. E. Herbison Kisspeptin Excites Gonadotropin-Releasing Hormone Neurons through a Phospholipase C/Calcium-Dependent Pathway Regulating Multiple Ion Channels Endocrinology, September 1, 2008; 149(9): 4605 - 4614. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gonzalez-Martinez, C. De Mees, Q. Douhard, C. Szpirer, and J. Bakker Absence of Gonadotropin-Releasing Hormone 1 and Kiss1 Activation in {alpha}-Fetoprotein Knockout Mice: Prenatal Estrogens Defeminize the Potential to Show Preovulatory Luteinizing Hormone Surges Endocrinology, May 1, 2008; 149(5): 2333 - 2340. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanda, Y. Akazome, T. Matsunaga, N. Yamamoto, S. Yamada, H. Tsukamura, K.-i. Maeda, and Y. Oka Identification of KiSS-1 Product Kisspeptin and Steroid-Sensitive Sexually Dimorphic Kisspeptin Neurons in Medaka (Oryzias latipes) Endocrinology, May 1, 2008; 149(5): 2467 - 2476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roa, E. Vigo, J. M. Castellano, F. Gaytan, V. M. Navarro, E. Aguilar, F. A. Dijcks, A. G. H. Ederveen, L. Pinilla, P. I. van Noort, et al. Opposite Roles of Estrogen Receptor (ER)-{alpha} and ER{beta} in the Modulation of Luteinizing Hormone Responses to Kisspeptin in the Female Rat: Implications for the Generation of the Preovulatory Surge Endocrinology, April 1, 2008; 149(4): 1627 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kinsey-Jones, X. F. Li, S. M. Luckman, and K. T. O'Byrne Effects of Kisspeptin-10 on the Electrophysiological Manifestation of Gonadotropin-Releasing Hormone Pulse Generator Activity in the Female Rat Endocrinology, March 1, 2008; 149(3): 1004 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Goodman, M. N. Lehman, J. T. Smith, L. M. Coolen, C. V. R. de Oliveira, M. R. Jafarzadehshirazi, A. Pereira, J. Iqbal, A. Caraty, P. Ciofi, et al. Kisspeptin Neurons in the Arcuate Nucleus of the Ewe Express Both Dynorphin A and Neurokinin B Endocrinology, December 1, 2007; 148(12): 5752 - 5760. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Dungan, M. L. Gottsch, H. Zeng, A. Gragerov, J. E. Bergmann, D. K. Vassilatis, D. K. Clifton, and R. A. Steiner The Role of Kisspeptin GPR54 Signaling in the Tonic Regulation and Surge Release of Gonadotropin-Releasing Hormone/Luteinizing Hormone J. Neurosci., October 31, 2007; 27(44): 12088 - 12095. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Dhillo, O. B. Chaudhri, E. L. Thompson, K. G. Murphy, M. Patterson, R. Ramachandran, G. K. Nijher, V. Amber, A. Kokkinos, M. Donaldson, et al. Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3958 - 3966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Rometo, S. J. Krajewski, M. Lou Voytko, and N. E. Rance Hypertrophy and Increased Kisspeptin Gene Expression in the Hypothalamic Infundibular Nucleus of Postmenopausal Women and Ovariectomized Monkeys J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2744 - 2750. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. d'Anglemont de Tassigny, L. A. Fagg, J. P. C. Dixon, K. Day, H. G. Leitch, A. G. Hendrick, D. Zahn, I. Franceschini, A. Caraty, M. B. L. Carlton, et al. Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene PNAS, June 19, 2007; 104(25): 10714 - 10719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamada, Y. Uenoyama, M. Kinoshita, K. Iwata, K. Takase, H. Matsui, S. Adachi, K. Inoue, K.-I. Maeda, and H. Tsukamura Inhibition of Metastin (Kisspeptin-54)-GPR54 Signaling in the Arcuate Nucleus-Median Eminence Region during Lactation in Rats Endocrinology, May 1, 2007; 148(5): 2226 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Kauffman, M. L. Gottsch, J. Roa, A. C. Byquist, A. Crown, D. K. Clifton, G. E. Hoffman, R. A. Steiner, and M. Tena-Sempere Sexual Differentiation of Kiss1 Gene Expression in the Brain of the Rat Endocrinology, April 1, 2007; 148(4): 1774 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Mead, J. J. Maguire, R. E. Kuc, and A. P. Davenport Kisspeptins Are Novel Potent Vasoconstrictors in Humans, with a Discrete Localization of Their Receptor, G Protein-Coupled Receptor 54, to Atherosclerosis-Prone Vessels Endocrinology, January 1, 2007; 148(1): 140 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Clarkson and A. E. Herbison Postnatal Development of Kisspeptin Neurons in Mouse Hypothalamus; Sexual Dimorphism and Projections to Gonadotropin-Releasing Hormone Neurons Endocrinology, December 1, 2006; 147(12): 5817 - 5825. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Thompson, K. G. Murphy, M. Patterson, G. A. Bewick, G. W. H. Stamp, A. E. Curtis, J. H. Cooke, P. H. Jethwa, J. F. Todd, M. A. Ghatei, et al. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1074 - E1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Castellano, M. Gaytan, J. Roa, E. Vigo, V. M. Navarro, C. Bellido, C. Dieguez, E. Aguilar, J. E. Sanchez-Criado, A. Pellicer, et al. Expression of KiSS-1 in Rat Ovary: Putative Local Regulator of Ovulation? Endocrinology, October 1, 2006; 147(10): 4852 - 4862. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tena-Sempere GPR54 and kisspeptin in reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 631 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Smith, S. M. Popa, D. K. Clifton, G. E. Hoffman, and R. A. Steiner Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. J. Neurosci., June 21, 2006; 26(25): 6687 - 6694. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roa, E. Vigo, J. M. Castellano, V. M. Navarro, R. Fernandez-Fernandez, F. F. Casanueva, C. Dieguez, E. Aguilar, L. Pinilla, and M. Tena-Sempere Hypothalamic Expression of KiSS-1 System and Gonadotropin-Releasing Effects of Kisspeptin in Different Reproductive States of the Female Rat Endocrinology, June 1, 2006; 147(6): 2864 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T Smith, D. K Clifton, and R. A Steiner Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling. Reproduction, April 1, 2006; 131(4): 623 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Dungan, D. K Clifton, and R. A. Steiner Minireview: Kisspeptin Neurons as Central Processors in the Regulation of Gonadotropin-Releasing Hormone Secretion Endocrinology, March 1, 2006; 147(3): 1154 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pompolo, A. Pereira, K. M. Estrada, and I. J. Clarke Colocalization of Kisspeptin and Gonadotropin-Releasing Hormone in the Ovine Brain Endocrinology, February 1, 2006; 147(2): 804 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Dhillo, O. B. Chaudhri, M. Patterson, E. L. Thompson, K. G. Murphy, M. K. Badman, B. M. McGowan, V. Amber, S. Patel, M. A. Ghatei, et al. Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6609 - 6615. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||